Is PHARMA TECHNOLOGY still active?

Yes, PHARMA TECHNOLOGY is currently active.

Where is PHARMA TECHNOLOGY registered?

PHARMA TECHNOLOGY's registered address is Rue Graham Bell 8, 1402 Nivelles, Belgium.

How many employees does PHARMA TECHNOLOGY have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), PHARMA TECHNOLOGY reported 69.9 full-time equivalent employees.

What is PHARMA TECHNOLOGY's annual turnover?

PHARMA TECHNOLOGY's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €26,773,124.

Did PHARMA TECHNOLOGY make a profit or a loss?

PHARMA TECHNOLOGY's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €3,773,369.

When did PHARMA TECHNOLOGY last file annual accounts?

PHARMA TECHNOLOGY's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is PHARMA TECHNOLOGY B Corp certified?

We have no B Corp certification on file for PHARMA TECHNOLOGY.

Does PHARMA TECHNOLOGY hold Fairtrade certification?

No, PHARMA TECHNOLOGY does not currently hold Fairtrade certification.

PHARMA TECHNOLOGY

Q: When was PHARMA TECHNOLOGY founded?

PHARMA TECHNOLOGY was founded on 29 Mar 1991, making it 35 years old.

Q: What does PHARMA TECHNOLOGY do?

PHARMA TECHNOLOGY's registered main activities are Manufacture of other special-purpose machinery n.e.c., Other manufacturing n.e.c., Manufacture of other general-purpose machinery and appliances n.e.c., and Warehousing and storage.

BE 0443.803.803

Copied!

NV/SA

Status

Active

Founded

29 Mar 1991

Size

Medium · 69.9 FTE

Age

35 yrs

Main activity

Manufacture of other special-purpose machinery n.e.c.

Activities

4 activities

Manufacture of other special-purpose machinery n.e.c.Other manufacturing n.e.c.Manufacture of other general-purpose machinery and appliances n.e.c.Warehousing and storage

Financials

Turnover2025

€26.8M+1.2%

Profit / Loss2025

€3.8M-13%

Equity2025

€16.3M+13.6%

2025	2024	2023	2022
€26,773,124+1.2%	€26,456,268+7.7%	€24,569,571+25.2%	€19,626,123
€3,773,369-13%	€4,338,486+10.3%	€3,932,494+30.1%	€3,022,644
€16,255,121+13.6%	€14,310,624+3.9%	€13,779,822-14.2%	€16,059,610
€7,397,742-17.8%	€9,002,736-23%	€11,697,382+20%	€9,750,464
€2,125,770-60.7%	€5,403,586+114.2%	€2,523,157-12.2%	€2,874,880
69.9+5.7%	66.1-1.5%	67.1+11.6%	60.1
€383,020-4.3%	€400,246+9.3%	€366,164+12.1%	€326,558

Frequently asked questions

01What is PHARMA TECHNOLOGY's official registered name?

PHARMA TECHNOLOGY.

02What is PHARMA TECHNOLOGY's enterprise number (VAT number)?

BE 0443.803.803.

03What is PHARMA TECHNOLOGY's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was PHARMA TECHNOLOGY founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€26,773,124+1.2%	€26,456,268+7.7%	€24,569,571+25.2%	€19,626,123
	€5,444,735+10.4%	€4,933,710-8.2%	€5,376,399+26%	€4,267,397
	€4,225,531-4.6%	€4,427,726+7.6%	€4,114,288+38.4%	€2,972,661
	€5,627,106-7.2%	€6,064,089+7.8%	€5,626,483+41.4%	€3,979,254
	€5,213,271-13%	€5,989,831+9.8%	€5,457,889+37.1%	€3,980,227
	€3,773,369-13%	€4,338,486+10.3%	€3,932,494+30.1%	€3,022,644
	€174,494+45.6%	€119,888-24.1%	€157,871	—
Profitability
	21.0%-8.3%	22.9%+0.1%	22.9%+13%	20.3%
	14.1%-14.1%	16.4%+2.5%	16.0%+3.9%	15.4%
	23.2%-23.4%	30.3%+6.2%	28.5%+51.6%	18.8%
	15.8%-14.4%	18.4%+20.5%	15.3%+31.8%	11.6%
Solvency
	€23,910,237+1.6%	€23,543,581-8.4%	€25,703,619-1.3%	€26,034,464
	€5,574,960-6.7%	€5,973,154-9.8%	€6,622,877+4.2%	€6,358,075
	€11,094>1000%	€325-0.1%	€325+0.3%	€324
	€16,255,121+13.6%	€14,310,624+3.9%	€13,779,822-14.2%	€16,059,610
	68.0%+11.9%	60.8%+13.4%	53.6%-13.1%	61.7%
	€545,256-34.2%	€828,346-30.7%	€1,194,588-8.8%	€1,309,491
	0.03-42%	0.06-33.2%	0.09+6.3%	0.08
	€7,397,742-17.8%	€9,002,736-23%	€11,697,382+20%	€9,750,464
	0.46-27.7%	0.63-25.9%	0.85+39.8%	0.61
	115.11+24.6%	92.36-38%	149.09+55.6%	95.85
Liquidity
	€2,125,770-60.7%	€5,403,586+114.2%	€2,523,157-12.2%	€2,874,880
	€6,957,538+32.2%	€5,263,690-10.1%	€5,856,877+1%	€5,801,648
	€5,057,313+30.6%	€3,872,161+50.3%	€2,576,045-72%	€9,200,584
	€2,163,589-4.5%	€2,265,192+29.9%	€1,743,360-25.9%	€2,352,930
	€6,845,029-14.5%	€8,004,635-23.4%	€10,455,522+27.1%	€8,226,423
	2.02+67.1%	1.21-9.7%	1.34-28.7%	1.88
	€9,110,374+28.2%	€7,106,473+17.1%	€6,071,218-40.9%	€10,278,903
Efficiency
	69 days+29.1%	53 days+39.6%	38 days-77.6%	171 days
	44 days-12.8%	51 days+16.8%	43 days-36.1%	68 days
	218 days+18.3%	184 days-6.8%	198 days-10.7%	221 days
	1.91+1.6%	1.88+1.1%	1.86+3.9%	1.79
Profit appropriation
	€2,300,000-38.6%	€3,744,740-39.1%	€6,150,000+23.4%	€4,984,853
	€1,728,088+128.9%	€754,818-3.4%	€781,424-6.9%	€839,310
	€13,185,521+3.9%	€12,685,422+5.1%	€12,065,071-15.2%	€14,224,029

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€26,773,124+1.2%	€26,456,268+7.7%	€24,569,571+25.2%	€19,626,123
	€5,444,735+10.4%	€4,933,710-8.2%	€5,376,399+26%	€4,267,397
	€4,225,531-4.6%	€4,427,726+7.6%	€4,114,288+38.4%	€2,972,661
	€5,627,106-7.2%	€6,064,089+7.8%	€5,626,483+41.4%	€3,979,254
	€5,213,271-13%	€5,989,831+9.8%	€5,457,889+37.1%	€3,980,227
	€3,773,369-13%	€4,338,486+10.3%	€3,932,494+30.1%	€3,022,644
	€174,494+45.6%	€119,888-24.1%	€157,871	—
Profitability
	21.0%-8.3%	22.9%+0.1%	22.9%+13%	20.3%
	14.1%-14.1%	16.4%+2.5%	16.0%+3.9%	15.4%
	23.2%-23.4%	30.3%+6.2%	28.5%+51.6%	18.8%
	15.8%-14.4%	18.4%+20.5%	15.3%+31.8%	11.6%
Solvency
	€23,910,237+1.6%	€23,543,581-8.4%	€25,703,619-1.3%	€26,034,464
	€5,574,960-6.7%	€5,973,154-9.8%	€6,622,877+4.2%	€6,358,075
	€11,094>1000%	€325-0.1%	€325+0.3%	€324
	€16,255,121+13.6%	€14,310,624+3.9%	€13,779,822-14.2%	€16,059,610
	68.0%+11.9%	60.8%+13.4%	53.6%-13.1%	61.7%
	€545,256-34.2%	€828,346-30.7%	€1,194,588-8.8%	€1,309,491
	0.03-42%	0.06-33.2%	0.09+6.3%	0.08
	€7,397,742-17.8%	€9,002,736-23%	€11,697,382+20%	€9,750,464
	0.46-27.7%	0.63-25.9%	0.85+39.8%	0.61
	115.11+24.6%	92.36-38%	149.09+55.6%	95.85
Liquidity
	€2,125,770-60.7%	€5,403,586+114.2%	€2,523,157-12.2%	€2,874,880
	€6,957,538+32.2%	€5,263,690-10.1%	€5,856,877+1%	€5,801,648
	€5,057,313+30.6%	€3,872,161+50.3%	€2,576,045-72%	€9,200,584
	€2,163,589-4.5%	€2,265,192+29.9%	€1,743,360-25.9%	€2,352,930
	€6,845,029-14.5%	€8,004,635-23.4%	€10,455,522+27.1%	€8,226,423
	2.02+67.1%	1.21-9.7%	1.34-28.7%	1.88
	€9,110,374+28.2%	€7,106,473+17.1%	€6,071,218-40.9%	€10,278,903
Efficiency
	69 days+29.1%	53 days+39.6%	38 days-77.6%	171 days
	44 days-12.8%	51 days+16.8%	43 days-36.1%	68 days
	218 days+18.3%	184 days-6.8%	198 days-10.7%	221 days
	1.91+1.6%	1.88+1.1%	1.86+3.9%	1.79
Profit appropriation
	€2,300,000-38.6%	€3,744,740-39.1%	€6,150,000+23.4%	€4,984,853
	€1,728,088+128.9%	€754,818-3.4%	€781,424-6.9%	€839,310
	€13,185,521+3.9%	€12,685,422+5.1%	€12,065,071-15.2%	€14,224,029

2025

2024

2023

2022

Income statement

€26,773,124+1.2%

€26,456,268+7.7%

€24,569,571+25.2%

€19,626,123

€5,444,735+10.4%

€4,933,710-8.2%

€5,376,399+26%

€4,267,397

€4,225,531-4.6%

€4,427,726+7.6%

€4,114,288+38.4%

€2,972,661

€5,627,106-7.2%

€6,064,089+7.8%

€5,626,483+41.4%

€3,979,254

€5,213,271-13%

€5,989,831+9.8%

€5,457,889+37.1%

€3,980,227

€3,773,369-13%

€4,338,486+10.3%

€3,932,494+30.1%

€3,022,644

€174,494+45.6%

€119,888-24.1%

€157,871

—

Profitability

21.0%-8.3%

22.9%+0.1%

22.9%+13%

20.3%

14.1%-14.1%

16.4%+2.5%

16.0%+3.9%

15.4%

23.2%-23.4%

30.3%+6.2%

28.5%+51.6%

18.8%

15.8%-14.4%

18.4%+20.5%

15.3%+31.8%

11.6%

Solvency

€23,910,237+1.6%

€23,543,581-8.4%

€25,703,619-1.3%

€26,034,464

€5,574,960-6.7%

€5,973,154-9.8%

€6,622,877+4.2%

€6,358,075

€11,094>1000%

€325-0.1%

€325+0.3%

€324

€16,255,121+13.6%

€14,310,624+3.9%

€13,779,822-14.2%

€16,059,610

68.0%+11.9%

60.8%+13.4%

53.6%-13.1%

61.7%

€545,256-34.2%

€828,346-30.7%

€1,194,588-8.8%

€1,309,491

0.03-42%

0.06-33.2%

0.09+6.3%

0.08

€7,397,742-17.8%

€9,002,736-23%

€11,697,382+20%

€9,750,464

0.46-27.7%

0.63-25.9%

0.85+39.8%

0.61

115.11+24.6%

92.36-38%

149.09+55.6%

95.85

Liquidity

€2,125,770-60.7%

€5,403,586+114.2%

€2,523,157-12.2%

€2,874,880

€6,957,538+32.2%

€5,263,690-10.1%

€5,856,877+1%

€5,801,648

€5,057,313+30.6%

€3,872,161+50.3%

€2,576,045-72%

€9,200,584

€2,163,589-4.5%

€2,265,192+29.9%

€1,743,360-25.9%

€2,352,930

€6,845,029-14.5%

€8,004,635-23.4%

€10,455,522+27.1%

€8,226,423

2.02+67.1%

1.21-9.7%

1.34-28.7%

1.88

€9,110,374+28.2%

€7,106,473+17.1%

€6,071,218-40.9%

€10,278,903

Efficiency

69 days+29.1%

53 days+39.6%

38 days-77.6%

171 days

44 days-12.8%

51 days+16.8%

43 days-36.1%

68 days

218 days+18.3%

184 days-6.8%

198 days-10.7%

221 days

1.91+1.6%

1.88+1.1%

1.86+3.9%

1.79

Profit appropriation

€2,300,000-38.6%

€3,744,740-39.1%

€6,150,000+23.4%

€4,984,853

€1,728,088+128.9%

€754,818-3.4%

€781,424-6.9%

€839,310

€13,185,521+3.9%

€12,685,422+5.1%

€12,065,071-15.2%

€14,224,029

PHARMA TECHNOLOGY

Activities

Financials

Frequently asked questions

All locations

All locations